| Title : Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy - Althurwi_2013_Br.J.Pharmacol_168_1794 |
| Author(s) : Althurwi HN , Tse MM , Abdelhamid G , Zordoky BN , Hammock BD , El-Kadi AO |
| Ref : British Journal of Pharmacology , 168 :1794 , 2013 |
| Abstract : Althurwi_2013_Br.J.Pharmacol_168_1794 |
| ESTHER : Althurwi_2013_Br.J.Pharmacol_168_1794 |
| PubMedSearch : Althurwi_2013_Br.J.Pharmacol_168_1794 |
| PubMedID: 23176298 |
| Title : Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice - Chaudhary_2013_Prostaglandins.Other.Lipid.Mediat_104-105_8 |
| Author(s) : Chaudhary KR , Zordoky BN , Edin ML , Alsaleh N , El-Kadi AO , Zeldin DC , Seubert JM |
| Ref : Prostaglandins Other Lipid Mediat , 104-105 :8 , 2013 |
| Abstract : Chaudhary_2013_Prostaglandins.Other.Lipid.Mediat_104-105_8 |
| ESTHER : Chaudhary_2013_Prostaglandins.Other.Lipid.Mediat_104-105_8 |
| PubMedSearch : Chaudhary_2013_Prostaglandins.Other.Lipid.Mediat_104-105_8 |
| PubMedID: 22922020 |
| Title : Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene - Aboutabl_2011_J.Cardiovasc.Pharmacol_57_273 |
| Author(s) : Aboutabl ME , Zordoky BN , Hammock BD , El-Kadi AO |
| Ref : J Cardiovasc Pharmacol , 57 :273 , 2011 |
| Abstract : Aboutabl_2011_J.Cardiovasc.Pharmacol_57_273 |
| ESTHER : Aboutabl_2011_J.Cardiovasc.Pharmacol_57_273 |
| PubMedSearch : Aboutabl_2011_J.Cardiovasc.Pharmacol_57_273 |
| PubMedID: 21383588 |